Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.

European journal of haematology(2023)

引用 0|浏览10
暂无评分
摘要
These findings are relevant for the future management of patients with hematological malignancies in COVID-19-affected regions.
更多
查看译文
关键词
COVID-19,anti-CD20 antibodies,hematological malignancies,hematological neoplasms,monoclonal antibodies
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要